Logo Nexira

Version française English

Neopuntia® Cacti-Nea™ et Bio Serae

Cacti-Nea, original cactus fruit ingredient

Cactus et Nexira, our comitment to sustainable development

Scientific background

A comprehensive set of studies was conducted on NeOpuntia® in order to confirm its lipophilic properties. The latest clinical study goes even further: it also reveals  its health benefits related to blood lipid levels regulation.


Lipophilic properties

  • NeOpuntia

    In vitro tests simulating gastro-intestinal conditions showed that :
  • NeOpuntia® could decrease fatty acid bioavailability by more than 28%.
  • NeOpuntia® lipophilic capacity is much higher than the one of Chitosan
  • A pilot clinical study also suggests that 1.6 g of NeOpuntia® per meal increases fat excretion on an average of 27%, compared to placebo.


Beyond weight management , for further health benefits...

  • Nexira conducted a larger study designed to assess NeOpuntia®'s ability to manage 5 risk factors typically associated with Metabolic Syndrome (Syndrome X).
    The study highlights that, along with a balanced diet and regular physical exercise,
    1.6g of NeOpuntia® per meal could help to :
  • Regulate some blood lipid parameters, which are generally associated with reduced cardio-vascular risks.
  • Positively influence Syndrome X diagnosis.
  • The results of this study are published : E. Linares et al. "The effect of NeOpuntia® on blood lipid parameters - Risk factors for the Metabolic Syndrome (Syndrome X)". Advances in Therapy Vol. 24; No.5, September/October 2007; (1113-1123 ).


» Feel free to contact us to get detailed results of the studies.

Copyright 2019 www.nexira.com | Website by Résonance Communication
NeOpuntia® and Cacti-Nea™ are trademarks of Nexira.